FRANKLIN RESOURCES INC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 75 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$70,200
-37.3%
20,6470.0%0.00%
Q3 2022$112,000
-50.7%
20,647
-46.9%
0.00%
Q1 2019$227,000
-98.7%
38,861
-97.8%
0.00%
-100.0%
Q4 2018$16,864,000
-46.2%
1,799,696
-2.2%
0.01%
-37.5%
Q3 2018$31,335,000
-12.3%
1,840,013
-12.5%
0.02%
-11.1%
Q2 2018$35,734,000
+29.8%
2,103,256
+2.5%
0.02%
+28.6%
Q1 2018$27,538,000
-14.1%
2,051,984
-38.5%
0.01%
-6.7%
Q4 2017$32,041,000
-7.0%
3,337,569
+6.4%
0.02%
-11.8%
Q3 2017$34,447,000
+22.7%
3,137,259
+1.1%
0.02%
+21.4%
Q2 2017$28,076,000
-30.5%
3,102,336
-1.5%
0.01%
-33.3%
Q1 2017$40,424,000
+33.1%
3,148,278
-2.6%
0.02%
+31.2%
Q4 2016$30,374,000
-4.7%
3,231,201
-1.4%
0.02%
-5.9%
Q3 2016$31,887,000
+45.0%
3,277,209
-0.0%
0.02%
+41.7%
Q2 2016$21,996,000
-42.4%
3,278,123
-23.5%
0.01%
-40.0%
Q1 2016$38,215,000
-44.2%
4,284,188
-17.1%
0.02%
-42.9%
Q4 2015$68,490,000
+15.8%
5,168,970
-7.9%
0.04%
+20.7%
Q3 2015$59,124,000
-53.8%
5,614,726
+19.3%
0.03%
-50.0%
Q2 2015$128,107,000
-13.7%
4,708,087
-2.9%
0.06%
-13.4%
Q1 2015$148,434,000
-14.8%
4,849,252
+4.2%
0.07%
-15.2%
Q4 2014$174,154,000
+12.8%
4,652,759
+5.3%
0.08%
+12.9%
Q3 2014$154,433,000
-21.8%
4,420,010
+4.2%
0.07%
-19.5%
Q2 2014$197,505,000
+218.4%
4,242,943
+111.3%
0.09%
+200.0%
Q1 2014$62,031,000
+243.9%
2,008,114
+155.2%
0.03%
+222.2%
Q4 2013$18,036,000786,9000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders